| http://www.w3.org/ns/prov#value | - U.S. Patent No. 5,230,346 discloses diagnostic accuracy rates of an estimated 79% sensitivity and 74% specificity by cross- validation. [0008] Thus, there is a need for systems and methods for analyzing and assessing dementia and dementia-type disorders. [0009] There is a further need for systems and methods for analyzing and assessing dementia and dementia-type disorders using non-linear type dat
|
